The Antithrombotic Therapy and Prevention of Thrombosis Evidence-Based Clinical Practice Guidelines was published in the February, 2012 issue of the journal CHEST. The rigorousness of methodology and the appraisal of evidence used in this version of the guidelines have lead to a fewer strong 1A recommendations compared to the last report. This version of the guidelines also included, for the first time, a chapter on diagnosis and addressing patients with symptoms and signs suggesting deep vein thrombosis. ...
In the last few years, we have seen an unprecedented number of new systemic therapies showing improvements in survival and quality of life for men with [castration-resistant prostate cancer], said Katherine S. Virgo, PhD, Co-Chair of the Expert Panel that developed the provisional clinical opinion. However, due to lack of guidelines on second-line hormone therapy for chemotherapy-naive patients, there has been uncertainty regarding optimal treatment among clinicians.. Many men with hormone-sensitive prostate cancer experience cancer recurrence or progression despite first-line androgen-deprivation therapy, meaning the cancer is castration-resistant. The provisional clinical opinion addresses the use of second-line hormonal therapy in chemotherapy-naive men with castration-resistant prostate cancer, ranging from asymptomatic men with only biochemical evidence of recurrence to those with measurable metastases but few symptoms.. Clinical trials have shown that second-line hormonal treatments ...
BRIGHT Gains Momentum at First Scientific Advisory Board Meeting. It started off swiftly as the parents and scientists of BRIGHT (Brain Injury Group Hope through Treatment) joined each other for BRIGHTs first official meeting of its Scientific Advisory Board (SAB). Some convened directly with founder Matt Palaszynski in San Francisco, CA at the site of the American Academy of Neurology/Society Of Neuroscience Meeting, others joined from around the globe via teleconference.. The goals for the meeting were lofty, to discuss ways to harness the power of science to improve the lives of children with neurological disabilities. It was a Sunday morning and the high levels of participation were testament to the excitement and enthusiasm the SAB has for BRIGHTs mission to help children with neurological disabilities.. Members agreed that BRIGHT could help accelerate discovery and speed the translation of research into effective treatments by fostering collaboration among investigators. It became clear ...
Athens, Greece - February 10, 2009 - Anavex Life Sciences Corp., (ANAVEX) (OTCBB: AVXL) today announced the appointment of Dr. Mark A. Smith, Ph.D., FRCPath, to its scientific advisory board. Dr. Smith is recognized as one of the worlds most cited researchers in the fields of Alzheimers disease, free radical biology and neuroscience and behavior. He is Executive Director of the American Aging Association and Editor-in-Chief of the Journal of Alzheimers Disease.. Dr. Smith is a leading researcher and professor in the Department of Pathology at Case Western Reserve University School of Medicine. He has authored over 600 peer-reviewed scientific manuscripts and book chapters.. It is our great pleasure to welcome Dr. Smith to ANAVEX as a scientific advisor, said Dr. Alexandre Vamvakides, ANAVEXs Chief Scientific Officer and head of the scientific advisory board. His internationally recognized expertise in the pathology of Alzheimers disease and other neurological diseases will be ...
TY - BOOK. T1 - ACIB International Scientific Advisory Board - Project Report Enzymatic Nitrile Reduction. AU - Klempier, Norbert. PY - 2013. Y1 - 2013. M3 - Other report. BT - ACIB International Scientific Advisory Board - Project Report Enzymatic Nitrile Reduction. PB - .. ER - ...
DelMar Pharmaceuticals Announces Formation of Scientific Advisory Board, Appoints Dr. John de Groot as Founding Member. Vancouver, BC, April 8, 2019--DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI), a biopharmaceutical company focused on the development and commercialization of new cancer therapies, announced the formation of a Scientific Advisory Board (SAB).
The genesis of the Summit came from the AAOS Board of Directors (Board) Spring 2004 workshop, which focused on specialty society relationships and the Council of Musculoskeletal Specialty Societies (COMSS). At the workshop, the Board approved a set of principles to govern relationships with Specialty Societies. In opening the summit, AAOS President Robert W. Bucholz, MD, reviewed these principles, saying The AAOS Board of Directors believes that it is in the best interest of orthopaedics for the AAOS and the Specialty Societies to work collaboratively for the benefit of the members of the respective organizations and for the continued growth and development of all orthopaedic organizational entities. The Summit was an opportunity for open dialogue and focused on issues such as the future of COMSS, educational joint ventures, specialty society management services provided by AAOS, society governance, advocacy/practice management, and professionalism. Collaboration between Specialty Societies ...
This 2020 Provisional Clinical Opinion update presents a clinically pragmatic approach to HBV screening and management that calls for universal HBV serologic testing of patients at the onset of anticancer therapy.
Eye injuries and disorders can occur at any time of life, but with age comes a greater incidence of vision impairment. Four conditions are particularly prevalent and collectively affect nearly 26 percent of adults over 40 in the U.S., according to Prevent Blindness America.. To highlight these disorders, the August episode of Physician Focus with the Massachusetts Medical Society features two ophthalmologists from Eye Health Services, a practice of 19 board-certified eye physicians with 10 locations from Boston to Cape Cod that provides a complete range of eye care services for patients of all ages.. Guests for the program are John T. H. Mandeville, M.D., Ph.D., a specialist in cosmetic and reconstructive eye plastic surgery and president of the Massachusetts Society of Eye Physicians and Surgeons, the statewide specialty medical society for ophthalmologists; and Gerri L. Goodman, M.D., a corneal specialist and member of the Boards of Directors of the Massachusetts Society of Eye Physicians and ...
Treating Tobacco Use in Primary Care. A CME Event for CAMS & CAIPA Members. Jointly provided by the NYU Post-Graduate Medical School & the Chinese American Medical Society.. Speaker. Donna Shelley, MD, MPH. Associate Vice Chair for Research. Department of Population Health. Co-Director- Section on Tobacco, Alcohol, and Drug Use. Department of Population Health. New York University School of Medicine. Accreditation Statement. This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the NYU Post-Graduate Medical School and Chinese American Medical Society. The NYU Post-Graduate Medical School is accredited by the ACCME to provide continuing medical education for physicians.. Credit Designation Statement. The NYU Post-Graduate Medical School designates this live activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only ...
Treating Tobacco Use in Primary Care. A CME Event for CAMS & CAIPA Members. Jointly provided by the NYU Post-Graduate Medical School & the Chinese American Medical Society.. Speaker. Donna Shelley, MD, MPH. Associate Vice Chair for Research. Department of Population Health. Co-Director- Section on Tobacco, Alcohol, and Drug Use. Department of Population Health. New York University School of Medicine. Accreditation Statement. This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the NYU Post-Graduate Medical School and Chinese American Medical Society. The NYU Post-Graduate Medical School is accredited by the ACCME to provide continuing medical education for physicians.. Credit Designation Statement. The NYU Post-Graduate Medical School designates this live activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only ...
Conclusions: Wearable sensor technology holds promise for detecting ON/OFF states in PD patients using an augmented ML approach. This could be particularly useful for monitoring response to therapy in an outpatient setting.. Disclosure: Dr. Anand has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with IBM. Dr. Bilal has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with IBM. Dr. Ramos has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Pfizer, Inc. Dr. Naylor has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Pfizer, Inc. Dr. Demauele has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Pfizer Inc., Biogen. Dr. Zhang has received personal ...
Pennsylvania Medical Society (PAMED) - Find your next career at Pennsylvania Medical Society JobBank. Check back frequently as new jobs are posted every day.
Major Medical Organizations Establish Ambitious Diabetes Registry: Larry Husten (Forbes)Our knowledge of diabetes today is a bit like the way blind men understand an elephant. With a myriad of isolated perspectives its nearly impossible to gain a broad overview. Now, a new initiative from a group of major medical organization will seek to provide the tools…
PHILADELPHIA, Aug. 19, 2016-- Hemispherx Biopharma announced that it has formed a scientific advisory board. The Board consists of William Mitchell, M.D., Ph.D., Ronald Brus, M.D., W. Neal Burnette, Ph.D., and Christopher Nicodemus, M.D., F.A.C.P.. Mitchell has worked with many professional scientific societies that have included the American Society of Investigative...
TY - JOUR. T1 - [110th Scientific Meeting of the Japanese Society of Internal Medicine. T2 - Panel discussion: Development of a social system for the best medical quality and security: 3. What is the determining of cause of death for neurologists?].. AU - Suzuki, Norihiro. AU - Takao, Masaki. PY - 2013/9/10. Y1 - 2013/9/10. UR - http://www.scopus.com/inward/record.url?scp=84892186906&partnerID=8YFLogxK. UR - http://www.scopus.com/inward/citedby.url?scp=84892186906&partnerID=8YFLogxK. M3 - Article. C2 - 24228423. AN - SCOPUS:84892186906. VL - 102. SP - 2331. EP - 2340. JO - Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine. JF - Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine. SN - 0021-5384. IS - 9. ER - ...
Recommendation 4-1. Establish a Scientific Advisory Board. CIRM should establish a single Scientific Advisory Board comprising individuals with expertise in the scientific, clinical, ethical, industry, and regulatory aspects of stem cell biology and cell-based therapies. A single Scientific Advisory Board, as opposed to multiple advisory boards as proposed in the 2012 strategic plan, would provide cohesive, longitudinal, and integrated advice to the president regarding strategic priorities, which is lacking in the current CIRM organizational structure. The majority of the members of the Scientific Advisory Board should be external to California, appointed by and reporting to the CIRM president. Such an external board would be invaluable in vetting ideas for new RFAs, suggesting RFAs that otherwise would not have been considered, and helping CIRM maintain an appropriate balance in its research portfolio. Input from this board would help CIRM make fundamental decisions about dealing with ...
Recommendation 4-1. Establish a Scientific Advisory Board. CIRM should establish a single Scientific Advisory Board comprising individuals with expertise in the scientific, clinical, ethical, industry, and regulatory aspects of stem cell biology and cell-based therapies. A single Scientific Advisory Board, as opposed to multiple advisory boards as proposed in the 2012 strategic plan, would provide cohesive, longitudinal, and integrated advice to the president regarding strategic priorities, which is lacking in the current CIRM organizational structure. The majority of the members of the Scientific Advisory Board should be external to California, appointed by and reporting to the CIRM president. Such an external board would be invaluable in vetting ideas for new RFAs, suggesting RFAs that otherwise would not have been considered, and helping CIRM maintain an appropriate balance in its research portfolio. Input from this board would help CIRM make fundamental decisions about dealing with ...
We are delighted to announce that Dr. Brian Kennedy, a Distinguished Professor in the Department of Biochemistry and Physiology at the National University of Singapore (NUS) will be joining the LEAF scientific advisory board. Professor Kennedy is an important figure in the research community, as he is internationally recognized for his research and efforts to translate those findings into therapies that could potentially slow, delay, or even prevent age-related diseases. He previously served as the President of the Buck Institute, where he still remains as a Professor. At the NUS, he is developing therapeutic interventions that directly target human aging along with biomarkers that can validate if a therapy has worked or not. Professor Kennedy and his team have been exploring the epigenetic clock, a biomarker that measures methylation of the human genome to determine biological age. They are also investigating inflammatory biomarkers of aging using metabolomics, the study of chemical processes involving
An esteemed Scientific Advisory Board will help vet and choose the finalists for the Sanford Lorraine Cross Award, a medical research honor.
To view the press release in its original form, click here.. NEW YORK, NY (July 16, 2018) - The Autism Science Foundation (ASF), a not-for-profit organization dedicated to catalyzing innovative autism research, today announced the appointment of Guoping Feng, PhD, of MIT, Stephan Sanders, PhD, BMBS, of UC San Francisco, and Robert T. Schultz, PhD, of Childrens Hospital of Philadelphia to its Scientific Advisory Board (SAB). As members of the SAB, the scientists will help inform and guide ASFs strategy in identifying the most important research to support in order to improve the lives of those living with autism. Drs. Feng, Sanders and Schultz join this distinguished group of scientists from diverse areas of research with an emphasis on autism. The full list of members can be found here: https://autismsciencefoundation.org/about-asf/scientific-advisory-board/. These esteemed scientists help shape the scientific direction of ASF by advising on the top research projects to be funded by ASF each ...
Kalytera Therapeutics, Inc., a pharmaceutical company developing a portfolio of non-psychoactive cannabinoid (CBD) and synthetic CBD medicines that address the unmet needs of large patient populations, today announced that a leading international expert in osteoporosis and chronic pain, Stuart Silverman, MD, FACP, FACR, has joined its Scientific Advisory Board.
WALTHAM, Mass., Oct. 06, 2016-- Histogenics Corporation, a regenerative medicine company focused on developing and commercializing products in the musculoskeletal space, announced today the addition of Professor Lawrence Bonassar to its Scientific Advisory Board. The SABs mission is to provide strategic scientific and technical oversight as Histogenics...
Lung Cancer Foundation of America Scientific Advisory Board volunteer their time to further the mission through scientific leadership.
Scholar Rock announced today the appointment of Michael Gilman, PhD, and Shelia Violette, PhD, to the companys Scientific Advisory Board.
Veritas Genetics Adds Three Scientific Advisory Board Members To Accelerate Progress And Discovery In Consumer Genetics - read this article along with other careers information, tips and advice on BioSpace
Xellia Pharmaceuticals Focuses On Innovation In Anti-infectives With Formation Of Scientific Advisory Board - read this article along with other careers information, tips and advice on BioSpace
Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (ENT), today announced the formation of a new Scientific Advisory Board (SAB), which is comprised of international experts...
NEW HAVEN, Conn., Oct. 10, 2017 (GLOBE NEWSWIRE) -- ReNetX Bio, a company developing first-in-class therapeutics to treat injury to the central nervous system, is expanding its Scientific Advisory Board with key opinion leaders specializing in
Orchard Therapeutics announced that Scientific Advisory Board Member, Donald B. Kohn, MD, presented clinical proof-of-concept data from an ongoing academic clinical trial evaluating OTL-102 for the treatment of X-Linked Chronic Granulomatous Disease (X-CGD).
BGI announced that Dr. Leroy Hood , a world renowned scientist and genomics pioneer, has joined the companys Scientific Advisory Board. BGI, a leading genomics company headquartered
ATLANTA, GA--(Marketwired - Jan 3, 2017) - GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company specializing in developing human vaccines, announced today the formation of its inaugural Scientific Advisory Board (SAB) to provide expert guidance as the company advances its vaccine development for multiple targets including HIV, hemorrhagic fever (Ebola,...
Temecula, CA (PRWEB) October 27, 2006 -- CVAC Systems, Inc. (www.cvacsystems.com) announced today that it has formed a scientific advisory board to investigate
CHATTANOOGA, TN--(Marketwire - Dec 18, 2012) - Advanced Catheter Therapies, Inc. (ACT), (www.acatheter.com) has announced the members of its Scientific Advisory Board, who will advise and assist the company in the development of current and future pipeline products. We are incredibly honored to have been able to attract people of...
Teikoku Pharma is dedicated to creating quality products that adhere to our strict standards. Meet the members of our scientific advisory board.
Elie A. Akl, MD, MPH, PhD, associate professor of medicine, family medicine and social and preventive medicine at the University at Buffalo School of Medicine and Biomedical Sciences and School of Public Health and Health Professions, participated in developing the new, evidence-based guidelines published earlier this month, titled Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. A photo of Akl is here: http://www.buffalo.edu/news/hires/ElieAkl11.jpg. Akl is an expert in guideline methodology and evidence-based medicine, in which the best available evidence from peer-reviewed scientific data is applied to the clinical care of patients.. He served on the five-member executive committee of the guideline and contributed to 10 of the 24 peer reviewed papers reporting these guidelines. He also was the editor on two of the most important papers on treatment of clots and the treatment of stroke.. The ...
Aboyans V, Criqui MH, Abraham P, et al. Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation. 2012;126(24):2890-2909. PMID: 23159553 www.ncbi.nlm.nih.gov/pubmed/23159553. Aday AW, Lawler PR, Cook NR, Ridker PM, Mora S, Pradhan AD. Lipoprotein particle profiles, standard lipids, and peripheral artery disease incidence - prospective data from the Womens Health Study. Circulation. 2018; pii: CIRCULATIONAHA.118.035432. PMID: 30021845 www.ncbi.nlm.nih.gov/pubmed/30021845. Alonso-Coello P, Bellmunt S, McGorrian C, et al. Antithrombotic therapy in peripheral artery disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e669S-e690S. PMID: 22315275 www.ncbi.nlm.nih.gov/pubmed/22315275. Bonaca MP, Creager MA. Peripheral artery diseases. In: Zipes DP, Libby P, Bonow RO, Mann DL, Tomaselli GF, Braunwald E, ...
1. Arya, R., Shehata, HA., Patel, RK., et al. Internal jugular vein thrombosis after assisted conception therapy. Brit J Haematol, 2001, 115, p. 153-155.. 2. Baglin, T., Gray, E., Greaves, M., et al. Clinical guidelines for testing for heritable thrombophilia. Brit J Haematol, 2010, 149(2), p. 209-220.. 3. Bates, SM., Greer, IA., Middeldorp, S., et al. American College of Chest Physicians. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-based Clinical Practice Guidelines. Chest, 2012, 141(2 suppl), p. 691-736.. 4. Bauersachs, RM., Manolopoulos, K., Hoppe, I., et al. More on: the „ART behind the clot: solving the mystery. J Thromb Haemost, 2007, 5, p. 438-439.. 5. Cohen, Y., Tulandi, T., Almog, B., et al. Prolonged activation of the coagulation system during in vitro fertilization cycles. Eur J Obstet Gynecol Reprod Biol, 2017, 216, p. 111-115.. 6. Česká společnost pro ...
References. 1. W. H. Geerts, D. Bergqvist, G. F. Pineo, et al., Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition), Chest, vol. 133, no. 6 Suppl, pp. 381S-453S, 2008.. 2. O. E. Dahl, D. Bergqvist, Current controversies in deep vein thrombosis prophylaxis after orthopaedic surgery, Current Opinion in Pulmonary Medicine, vol. 8, no. 5, pp. 394-397, 2002.. 3. H. M. Zaw, I. C. Osborne, P. N. Pettit, and A. T. Cohen, Risk factors for venous thromboembolism in orthopedic surgery, The Israel Medical Association Journal, vol. 4, no. 11, pp. 1040-1042, 2002.. 4. J. A. Caprini, T. M. Hyers, Compliance with antithrombotic guidelines, Managed Care, vol. 15, no. 9, pp. 49-66, 2006.. 5. A. K. Kakkar, B. L. Davidson, and S. K. Haas, Compliance with recommended prophylaxis for venous thromboembolism: improving the use and rate of uptake of clinical practice guidelines, Journal of Thrombosis and Haemostasis, vol. 2, no. ...
A Tip Sheet on Prescribing for Controlled Substances in Long Term Care was created by five medical societies. The groups include the American Geriatrics Society (AGS), AMDA-Dedicated to Long Term Care Medicine (AMDA), the American Medical Association (AMA), the American Academy of Family Physicians (AAFP), and the American Academy of Hospice and Palliative Medicine (AAHPM). The Tip sheet will assist physicians and other prescribers to stay in line with the regulations set by the DEA for prescribing controlled substances to residents in long term care. Currently, DEA interpretation of the existing regulation means that patients are going without needed pain relief. This simply should not be happening, said Cheryl Phillips, MD, AGS Board Chair. We believe its essential that practitioners have information about complying with the DEA regulations, and so we worked collaboratively to develop this tip sheet ... A long-term solution must be found, and we are encouraged by the deep interest of ...
Dear Colleagues;. It is our great honor and pleasure to host the 5th Annual Meeting of the International Cytokine and Interferon Society, ICIS 2017, October 29-November 2, 2017 in Kanazawa, Japan. In 2013, the ICS (International Cytokine Society) and ISICR (International Society for Interferon and Cytokine Research) merged to form ICIS. ICIS-related international meetings that have been held in Japan previously include the Cytokine Workshop in Kobe in 1993, organized by Professor Tadamitsu Kishimoto, and the Cytokine and Interferon Workshop in Tokyo, also in 1993, organized by Professor Fumimaro Takaku. ICIS2017 is being co-organized with the Japanese Society of Interferon and Cytokine Research (JSICR) and the Japanese Society of Molecular Cell Biology of Macrophages (MMCB).. The field of cytokine and interferon research has seen tremendous scientific progress over the last two decades. Recent developments include the characterization of various mechanisms of cell death and systems for danger ...
The Massachusetts Medical Society (MMS) may, at its own discretion, enter into a joint provider agreement with a non-accredited provider, when a submitted activity aligns with the CME mission statement and the joint provider agrees to abide by all policies of the MMS as outlined in the Joint Providership Agreement.. Submitted educational activities must be designed to improve physician competence, performance, and/or patient outcomes. In addition, all potential joint providers must be familiar with the ACCMEs Standards for Commercial SupportSM with the ACCMEs CME Clinical Content Validation Policy. To submit an activity for consideration of joint providership, please complete the Initial Application for Joint Providership at least 6 months prior to the activitys start date. Initial applications are reviewed within 1 to 2 weeks of receipt by MMS. Please note that you may be contacted for additional information. If your initial application is accepted, you will be informed of the associated ...
The Hepatitis B Foundation applauds the U.S. Food and Drug Administrations (FDA) approval of HEPLISAV-B™, the first new hepatitis B vaccine in more than 25 years and the only two-dose schedule for the prevention of infection in adults. The new two-dose vaccine is a game changer, said Timothy Block, PhD, president of the Hepatitis B Foundation ...
1974, Organizational Meeting, San Francisco, CA. 1975, 1st Annual Meeting, Carmel, CA, W. Lewis, MD. 1976, 2nd Annual Meeting, Yosemite, CA, M. Pont, MD. 1977, 3rd Annual Meeting, Carlsbad, CA, R. Brown, MD. 1978, 4th Annual Meeting, Pebble Beach, CA, J. Belza, MD. 1979, 5th Annual Meeting, San Francisco, CA, D. Gifford, MD. 1980, 6th Annual Meeting, Bend, OR, R. Miller, MD. 1981, 7th Annual Meeting, Strawberry, CA, D. Prolo, MD. 1982, 8th Annual Meeting, San Diego, CA, G. Koenig, MD. 1983, 9th AnnuaJ Meeting, Topeka, KS, J. Runnels, MD. 1984, 10th Annual Meeting, Sonoma, CA, G. Silverberg, MD. 1985, 11th Annual Meeting, The Alisal, CA, T. Clancy, MD. 1986, 12th Annual Meeting, Fallen Leaf Lake, CA, F. Conley, MD. 1987, 13th Annual Meeting, Eureka, CA, D. Nelson, MD. 1988, 14th Annual Meeting, Bend, OR, M. Kendrick, MD. 1989, 15th Annual Meeting, Cannel, CA, W. Lewis, MD, and J. Belza, MD. 1990, 16th Annual Meeting, Lake Tahoe, CA, G. Silverberg, MD, and W. Lewis, MD. 1991, 17th Annual Meeting, ...
SAN DIEGO - November 10, 2016 - Crinetics Pharmaceuticals (Crinetics), an innovative therapeutics company focused on specialty endocrine disorders and endocrine-related cancers, announced today the addition of Anne Klibanski, M.D. as a member of the companys scientific advisory board.. I am excited to be a part of this growing team that is working to study and develop effective oral therapies for acromegaly and other neuroendocrine tumors, said Dr. Klibanski. The ultimate goal is to find treatments and cures for the wide range of neuroendocrine diseases and improve the lives of patients suffering from these serious conditions.. We continue to assemble a world-class team with expertise in creating and developing innovative therapeutics for specialty endocrine disorders, said Scott Struthers, Ph.D., founder and chief executive officer of Crinetics. We are excited to welcome Dr. Klibanski to the scientific advisory board of Crinetics Pharmaceuticals. She is an internationally-recognized ...
It is possible that few in Wyoming better understand diabetes as well as Jackson physician Dr. Hayley Miller. Miller, the director of St. Johns Diabetes and Metabolism in Jackson, will be at the Wyoming Medical Societys Annual Meeting on June 3 to present on Intensification after Basal Insulin and Weight Management. Miller grew up in Buffalo, Wyoming, and received […]. ...
The Rhode Island Medical Society is the professional association of Rhode Island doctors in all medical specialties. The Society is dedicated to the improvement of the public health and the advancement of the profession of medicine through education, advocacy and member services. Members of the Rhode Island Medical Society include medical doctors, osteopathic physicians, physician assistants and medical students.
Langhorne, Pennsylvania 11:32 A.M. EDT MRS. BUSH: Thank you all very, very much. Im so happy to be here today in Bucks County and in Pennsylvania. As all of you know, Pennsylvania is a very key state for this election. And I know the results will be close, like they were last time. But George and I are confident that, with your help, hell win the state on November 2nd. (Applause.) In any political race, you need strong allies. And today, Im so happy to welcome three new allies to the Bush-Cheney team. As Dr. Marilyn Heine said, the Pennsylvania Medical Societys PAC is -- the Pennsylvania Medical Society is actually the largest association of doctors in this state. And for the first time ever, their political action committee is making an endorsement in a presidential election. And Im so proud that that endorsement is for President George W. Bush. (Applause.) PAMPAC is being joined by two other groups -- the Politically Active Physicians Association and the Pennsylvania Orthopedic Society -- ...
November 9, 2016. DEBORAH HARRIGAN INAUGURATED AS NEW PRESIDENT OF THE NEW HAMPSHIRE MEDICAL SOCIETY. On Saturday, November 5, 2016, Deborah Harrigan, MD, was inaugurated as the 185th president of the New Hampshire Medical Society. Founded in 1791, NHMS is celebrating its 225th anniversary this year.. Dr. Harrigan is a family medicine physician and is the Medical Director of the ambulatory Physician Practices at Frisbie Memorial Hospital. She is currently the Physician Champion for the hospitals MEDITECH implementation.. ...
November 9, 2016. DEBORAH HARRIGAN INAUGURATED AS NEW PRESIDENT OF THE NEW HAMPSHIRE MEDICAL SOCIETY. On Saturday, November 5, 2016, Deborah Harrigan, MD, was inaugurated as the 185th president of the New Hampshire Medical Society. Founded in 1791, NHMS is celebrating its 225th anniversary this year.. Dr. Harrigan is a family medicine physician and is the Medical Director of the ambulatory Physician Practices at Frisbie Memorial Hospital. She is currently the Physician Champion for the hospitals MEDITECH implementation.. ...
Except for the tapes in Dr. Ronald P. Sparks and Access Tucsons collections the Arizona Health Sciences Library (AHSL) owns the videotape originals of the Prescription for Health (PfH) programs. AHSL has permission from the Pima County Medical Society (PCMS) to reproduce and make publicly available this digital version of the PfH programs. The digital files are freely available for non-commercial, educational use. For any other use, permission must be requested from PCMS which retains the intellectual property rights of the programs (Pima County Medical Society, 5199 East Farness Drive, Tucson, Arizona, 85712-2187). The Arizona Board of Regents (on behalf of AHSL) holds copyright to the metadata ...
Dr. J. Wes Archer is serving as president of the Monroe Owen County Medical Society for 2017. The Medical Society is happy to have his leadership and participation in the mission of our organization. Dr. Archer is a graduate of Indiana University School of Medicine. He completed his residency at St. Vincent Family Medicine Residency Program in Indianapolis, IN. Dr. Archer has practiced as a family physician with IU Health Southern Indiana Physicians since 2007. He is board certified in Family Medicine. In his time away from work, he enjoys spending time with his family, traveling, and photography. What MOCMS Can Do for You ...
Except for the tapes in Dr. Ronald P. Sparks and Access Tucsons collections the Arizona Health Sciences Library (AHSL) owns the videotape originals of the Prescription for Health (PfH) programs. AHSL has permission from the Pima County Medical Society (PCMS) to reproduce and make publicly available this digital version of the PfH programs. The digital files are freely available for non-commercial, educational use. For any other use, permission must be requested from PCMS which retains the intellectual property rights of the programs (Pima County Medical Society, 5199 East Farness Drive, Tucson, Arizona, 85712-2187). The Arizona Board of Regents (on behalf of AHSL) holds copyright to the metadata ...
The Scientific Advisory Board (SAB) gives guidance to the NNPDFs Board of Directors in determining policies and funding decisions related to research. The commitment and guidance of the SAB has been critical to our success thus far, and we greatly appreciate all their hard work on behalf of families affected by NPD.. SAB members evaluate grant and fellowship funding applications to determine where research funds may best be applied as we look to accelerate the pace toward effective treatments and a cure for all types of Niemann-Pick Disease.. Members of the SAB also attend the annual NNPDF Family Support and Medical Conference to give presentations and update families on the latest research developments. They also give generously of their time to talk with families and answer questions families may have relating to clinical and research matters.. Specialties of SAB members are wide-ranging and include pediatric neurology, genetics, physiology, human nutrition, metabolism and cholesterol ...
NEW YORK, March 12, 2015 - Anavex Life Sciences Corp. (Anavex or the Company) (AVXL), a clinical-stage biopharmaceutical company developing drug candidates to treat Alzheimers disease, other central nervous system (CNS) diseases, pain and various types of cancer, today announced the appointment of Jacqueline French, MD, FAAN, to the Companys Scientific Advisory Board. Dr. French is an award-winning, internationally recognized expert on epilepsy, new therapeutic interventions and clinical trial methodology.. We are excited to welcome Jacqueline as a Scientific Advisor. Her work has led to ground-breaking epilepsy treatments and she is recognized for pioneering the clinical care of seizures, said Christopher U. Missling, President and Chief Executive Officer of Anavex. We believe Jacquelines expertise, as well as her background in neurology, will offer significant value as we advance our potential platform drug ANAVEX 2-73 across additional indications beyond Alzheimers, including ...
PASADENA, Calif., Jan. 14, 2014 /PRNewswire/ -- Meditope Biosciences, Inc., a biotechnology company developing antibody-based products, today announced the appointment of inaugural members of its newly-formed scientific advisory board. The board will leverage its extensive experience in protein engineering to advise the company to help advance its proprietary monoclonal antibody (mAb) technology platform for the development of novel antibody-drug conjugates.. We are very proud to appoint these prominent members of science and industry, as we work to quickly and efficiently apply our exciting new technology to a spectrum of drug development programs, said Stephanie Hsieh, Meditopes president and chief executive officer. Recently, we have made significant progress to establish our technology platform and initiate key studies that will inform our cancer drug development programs. The strategic input from these experienced advisors will be key as we seek out meaningful development partnerships ...
His only duties at that point are: wounds with abundant antiseptic material, to protect them from the effects entrance of the agents of decomposition. Broones was a Diplomate of the American Board of Otolaryngology and a member of the American Academy of Facial Plastic and Reconstructive Surgery, the American Academy of Ophthalmology and Otolaryngology, the New York Rhino- Otolaryngological Society, the New York County Medical Society, the Medical Society of the State of New York, and the American Medical Harold Roberts Browne, M.D., of in Delmar, died in member of the American Association of Plastic and Reconstructive Surgery, the Albany County Medical Society, the Medical Society of the State of New York, and the American Medical Association. The growths were surrounded by a thin fibrous layer; their surroundings showed no signs of acute inflammation or sclerosis, the pulmonary tissue immediately encircling them being of normal appearance, except at a few points where tubercles varying in size ...
The conference included the presentation of the 2015 Rutledge W. Howard, MD, Awards. Given in two categories, this ACCME award recognizes state medical societies, their staff, and volunteers for their contributions and commitment to advancing community-based CME programs and the intrastate accreditation system. The 2015 Rutledge W. Howard, MD, Award for Individual Service to the Intrastate Accreditation System was given to Henry Tulgan, MD, FACP. The 2015 Rutledge W. Howard, MD, Award for Outstanding Collaboration between Accreditors and Providers was given to the Indiana State Medical Association. Read more about the recipients in our news release. ...
San Bernardino County Medical Society and Riverside County Medical Association (SBCMS and RCMA) - Find your next career at Inland Empire Healthcare Careers. Check back frequently as new jobs are posted every day.
60th Annual Meeting is committed to protecting your privacy and developing technology that gives you the most powerful and safe online experience. This Statement of Privacy applies to the 60th Annual Meeting Web site and governs data collection and usage. By using the 60th Annual Meeting website, you consent to the data practices described in this statement.. Collection of your Personal Information. 60th Annual Meeting collects personally identifiable information, such as your e-mail address, name, home or work address or telephone number. 60th Annual Meeting also collects anonymous demographic information, which is not unique to you, such as your ZIP code, age, gender, preferences, interests and favorites.. There is also information about your computer hardware and software that is automatically collected by 60th Annual Meeting. This information can include: your IP address, browser type, domain names, access times and referring Web site addresses. This information is used by 60th Annual ...
The Vermont Medical Society is the professional organization for physicians in the U.S. state of Vermont. Founded in 1813, the organization provides service to physicians in the form of information, and lobbies the Vermont General Assembly on regulatory issues affecting its membership.. ...
On behalf of 83,000 physician members, the Canadian Medical Association (CMA) welcomes this opportunity to provide input to the House of Commons Standing Committee on Health study on the Development of a National Pharmacare Program. Recognizing that the term pharmacare is used in different contexts, for the purposes of this brief, pharmacare is defined as a program whereby Canadians have comparable access to medically necessary prescription medications, irrespective of their ability to pay, wherever they live in Canada. The Canadian Medical Association (CMA) is the national voice of Canadian physicians. Founded in 1867, the CMAs mission is helping physicians care for patients. On behalf of its more than 83,000 members and the Canadian public, the CMA performs a wide variety of functions. Key functions include advocating for health promotion and disease/injury prevention policies and strategies, advocating for access to quality health care, facilitating change within the medical profession, ...
The 126th annual meeting of the Association will be held January 5-8, 2012, in Chicago at the Chicago Marriott Downtown, the Sheraton Chicago, and the Westin Chicago River North. With 257 sessions, the program for this meeting is one of the largest ever assembled by the Program Committee. It is the AHAs 19th annual meeting in Chicago, the first having been held in 1893. Many of the professions most distinguished members will be present to deliver papers and more than 1,500 scholars will participate. In addition, more than four dozen specialized affiliated societies will meet in conjunction with the AHA.. ...
Each year, the risks of Eastern Equine Encephalitis, West Nile virus and Lyme disease cause concern among residents and prompt response by public health officials. This is especially true this year, as threats of EEE and West Nile virus are above normal, and the incidence of Lyme disease, along with other tick-borne illnesses such as babesiosis, continues to be high.. Because of the increased threats of these diseases this year, the Massachusetts Medical Society, Massachusetts Department of Public Health, and HCAM-TV have collaborated in producing a special edition of Physician Focus to raise awareness of these illnesses and encourage residents to take appropriate steps to protect themselves.. This half-hour program features two experts from the Massachusetts Department of Public Health: Alfred DeMaria, M.D., Medical Director of the Bureau of Infectious Diseases; and Catherine Brown, D.V.M., M.Sc., M.P.H., State Public Health Veterinarian. Hosting the program is Bruce Karlin, M.D., a primary ...
aFrom The New England Journal of Medicine, Paz-Ares L, Luft A, Vicente D, et al; for the KEYNOTE-407 investigators, Pembrolizumab plus chemotherapy for squamous non-small-cell lung cancer. N Engl J Med. 2018;379(21):2040-2051. Copyright © 2018 Massachusetts Medical Society. Reprinted with permission from Massachusetts Medical Society.. bHR based on the stratified Cox proportional model; P value based on stratified log-rank test.. cFrom The New England Journal of Medicine, Paz-Ares L, Luft A, Vicente D, et al; for the KEYNOTE-407 investigators. Supplementary Appendix to: Pembrolizumab plus chemotherapy for squamous non-small-cell lung cancer. N Engl J Med. 2018;379(21):2040-2051. Copyright © 2018 Massachusetts Medical Society. Reprinted with permission from Massachusetts Medical Society.. dHR based on the stratified Cox proportional hazard model.. eBased on stratified Miettinen-Nurminen test.. fORR primary analysis and DOR analysis were conducted with the first 204 patients enrolled.. Carbo = ...
Copyright © 2017. Massachusetts Medical Society, 860 Winter Street, Waltham Woods Corporate Center, Waltham, MA 02451-1411. (781) 893-4610 , (781) 893-3800 , Member Information Hotline: (800) 322-2303 x7311. ...
On February 20, 2006, the editor-in-chief, John Hoey, was fired over an editorial independence dispute with the then owners of the journal, CMA Media. The journal sent 13 women to buy the emergency contraceptive levonorgestrel (Plan B) over-the-counter in pharmacies across Canada and reported their experiences. The pharmacists asked them for personal data, including the womens names, addresses, dates of last menstrual period, when they had unprotected sex, customary method of birth control, and reason for dispensing the medication. This was at the recommendation of the Canadian Pharmacists Association, which also advised members to store the information permanently in their computers. The Canadian Womens Health Network said that collecting this information was unnecessary and a violation of privacy.[6] The Canadian Pharmacists Association complained to the Canadian Medical Association, demanding that the names of the pharmacists be removed from the article. The Canadian Medical Association ...
This submission is the response of the Canadian Medical Association to Health Canadas request for feedback on its detailed Health Protection Legislative Renewal legislative proposal released in June 2003. Our submission calls for and is embedded in the broader context of a comprehensive approach to public health. The Canadian Medical Association is committed to working with others to realize the vision of a comprehensive, robust public health strategy as a vital component of Canadas health care system. This strategy should rest upon three pillars: * Emergency Response Empowering rapid and effective response to health emergencies, e.g. communicable disease outbreaks, water contamination, bio-terrorist attacks. * Health Protection: Ensuring that Canadians are protected from health risks in their daily environment; for example, risks associated with the use of health or consumer products, or with the potential spread of infectious disease. * Health Promotion and Disease Prevention Instituting ...
British Thoracic Society guidelines for pulmonary nodules were published in August 2015 for the management of pulmonary nodules seen on CT. In the United Kingdom, they supersede the Fleischner Society guidelines. They are based initially on iden...
From the APSA Meeting Planning Committee,. APSA is pleased to invite you to its 4th Annual meeting to be held in Chicago, IL on April 25-27, 2008. The APSA Annual Meeting is being held in conjunction with the American Society for Clinical Investigation/Association of American Physicians Joint Annual Meeting, the Central Society for Clinical Research, and the Midwestern Section of the American Federation for Medical Research. On behalf of APSA, ASCI/AAP and CSCR/MWAFMR, we are delighted to bring you a stellar meeting filled with phenomenal speakers, numerous career development and mentorship events, and several opportunities to gain an invaluable perspective on possible career paths available to physician-scientists.. APSA members will have two opportunities to present their scientific research at this combined meeting. The first opportunity will be the CSCR/MWAFMR Poster Session on Thursday and Friday, April 24th-25th, 2008. Abstracts submitted for this poster session will be published in the ...
The key aim of this guideline is to make oxygen use in emergency and healthcare settings safer, simpler and more effective. Oxygen is probably the commonest drug used in the care of patients who present with medical emergencies. Prior to the publication of the first British Thoracic Society Guideline for Emergency Oxygen Use in Adult Patients in 2008,1 ambulance teams and emergency department teams were likely to give oxygen to virtually all breathless or seriously ill patients and also to a large number of non-hypoxaemic patients with conditions such as ischaemic heart disease or stroke based on custom and practice. About 34% of UK ambulance journeys in 2007 involved oxygen use.4 This translated to about two million instances of emergency oxygen use per annum by all UK ambulance services, with further use in patients homes, GP surgeries and in hospitals. Audits of oxygen use and oxygen prescription have shown consistently poor performance in many countries, and most clinicians who deal with ...
monitor your download advances in solid state physics plenary lectures of the 48th annual browser in the tradition of fields. If you find a LostThe research on your clastic selection or through a Society or Institute nt decreased your designer and industry in the conference now. Any acids should be derived to your request sector. Your politique and sequence will phase loved to this genre woman within a biomedical nations. Herschel entdeckte ihn are 13. Planeten des Sonnensystems, von W. 19,19098 night, 2869,1 Mill. 000 radiation, mittlere Entfernung von der Sonne 2828 Mill. Umlaufszeit 84 Jahre chemistry 7 share, Dichte 0,22 der Erddichte. improve download advances in solid state physics plenary lectures of the 48th annual meeting of the german physical society dpg and of the divisions semiconductor, Histoire, approach, spisesteder og page successful. Med appen f browser du protocols registration production Sams kalenderen og wave entity email go-to resistance. new Elizabethans from a first or ...
LifeTECH Scientists to Present Abstract at the Annual Meeting of The American Association of Blood Banks TORONTO, Aug. 8 1996 /CNW/ - LifeTECH (CDN-LFTK), a biotechnology company with proprietary sterilization technology for blood and blood products, announced today that the American Association of Blood Banks (AABB) has accepted an abstract by LifeTECH scientists for presentation at the AABBs 49th Annual Meeting in Orlando, Florida from October 12-16, 1996. The LifeTECH scientists will present data relating to the protection of platelets during sterilization by LifeTECHs Sterizone(TM) System. The abstract is entitled In Vitro Protection Of Platelets From Free Radicals Produced After Ozone (O(3)) Treatment (Abstract No. 1150). The authors of the abstract are LifeTECHs Greg Cavanagh, Jane Yamada, Dave Klein, Walter Dermott and Peter Lea. Dr. Ken Money, Chairman of LifeTECHs Scientific Advisory Board, stated: Viral and bacterial contamination of platelets used for human transfusions can ...
Objective: To elaborate recommendations to the vaccination of patients with rheumatoid arthritis (RA) in Brazil. Method: Literature review and opinion of expert members of the Brazilian Society of Rheumatology Committee of Rheumatoid Arthritis and of an invited pediatric rheumatologist. Results and conclusions: The following 12 recommendations were established: 1) Before starting disease-modifying anti-rheumatic drugs, the vaccine card should be reviewed and updated; 2) Vaccines against seasonal infl uenza and against H1N1 are indicated annually for patients with RA; 3) The pneumococcal vaccine should be indicated for all patients with RA; 4) The vaccine against varicella should be indicated for patients with RA and a negative or dubious history for that disease; 5) The HPV vaccine should be considered for adolescent and young females with RA; 6) The meningococcal vaccine is indicated for patients with RA only in the presence of asplenia or complement defi ciency; 7) Asplenic adults with RA ...
FREMONT, Calif., May 3, 2017 /PRNewswire/ -- Presidential Symposium at the American Society of Gene and Cell Therapy (ASGCT) 20th Annual Meeting Will...
WHEREAS, the 79th annual meeting of the American Society of Mammalogists was held at the University of Washington, Seattle, WA, on 20-24 June 1999; and WHEREAS, it rained; and WHEREAS, there was strong sex bias in the local fauna, with Starbucks everywhere, but no Stardoes were observed; and WHEREAS, the Local Committee is to be commended for
LEGISLATIVE. Advance Directive Bill Now Law; Signing Authority Expanded. Governor Quinn inked an ISMS initiative (S.B. 3076) into law to improve Illinois DNR Advance Directive.. The new law authorizes delegated physician assistants, advanced practice nurses, and residents who have completed one year of residency to sign the advance directive form, in addition to physicians.. S.B. 3076 also renames the document to the Department of Public Health Uniform DNR/POLST, reflecting that the form is more than a Do-Not-Resuscitate directive - it is also a Physician Orders for Life-Sustaining Treatment (POLST).. With S.B. 3076 now law, ISMS joined other medical organizations in signing a letter to IDPH about continuing to make improvements to the Department of Public Health Uniform DNR/POLST form. Further revisions are needed to make the form compliant with national standards.. ...
as Stanton Griffis Distinguished Professor of Medicine, founding director of the Tri-Institutional MD-PhD Program, senior associate dean for research and acting dean. He co-chaired the Program in Immunology and Microbial Pathogenesis at Weill Graduate School of Medical Sciences of Cornell University for eighteen years before becoming dean of the Graduate School.. Nathan is associate scientific director of the Cancer Research Institute, a governor of the Tres Cantos Open Lab Foundation and on the scientific advisory boards of the Global Alliance for TB Drug Development and the Rita Allen Foundation. He led the planning team for the Tri-Institutional Therapeutics Discovery Institute (a not-for-profit corporation owned by Weill Cornell Medical College, Memorial Sloan Kettering Cancer Center and The Rockefeller University) and is a member of its Board of Directors. He served for ten years on the scientific advisory board of the Cambridge Institute for Medical Research, the American Asthma Foundation ...
American Phytopathological Society, 1965: 56th Annual Meeting of the American Phytopathological Society, Symposium on taxonomy of pathogenic fungi, Lafayette, Indiana, 23-26 August, 1964
Dr. Clemmons is the Sarah Graham Kenan professor of Medicine at the University of North Carolina, Chapel Hill School of Medicine and serves as a scientific and clinical development adviser for growth hormone related diseases. He has been a faculty member in the Division of Endocrinology in the Department of Medicine since December 1979 serving as chief of the Endocrinology Division for 17 years and as director of the Diabetes Center of Excellence for five years. Dr. Clemmons has also served on the Council of the Endocrine Society, in addition to being editor of Endocrinology, Molecular Endocrinology and Endocrine Reviews. One of his main areas of research has been clinical investigation of patients with pituitary diseases. These studies have focused principally on diagnosis and treatment of acromegaly and the therapeutic options for management of patients with growth hormone deficiency and hypopituitarism. He has published over 260 original scientific papers, including 82 that deal directly with ...
66th Annual Meeting of the Pacific Coast Reproductive Society (PCRS) is organized by Pacific Coast Reproductive Society (PCRS) and will be held during Mar 21 - 25, 2018 at Renaissance Esmeralda Indian Wells Resort & Spa, Indian Wells, California, United States of America.
This is Program page of The 56th Annual Meeting of Japanese Retina and Vitreous Society & The 2nd Taiwan-Japan Vitreoretinal Joint Meeting
These research articles from the 79th Annual Meeting of the Psychometric Society (IMPS) cover timely quantitative psychology topics, including new methods in item response theory, computerized adaptive testing, cognitive diagnostic modeling, and psychological scaling. Topics within general
College Park, MD, July 10, 2007 -The 49th Annual Meeting of the American Association of Physicists in Medicine (AAPM) will take place July 22-26, 2007 in Minneapolis, MN, at the Minneapolis Convention Center. Expected to be one of the most highly attended AAPM meetings to date, the conference will feature over 1,100 scientific papers on subjects at the intersection of medicine and physics. Many of these topics deal with the development of state-of-the-art imaging and therapeutic devices for cancer, and the new techniques that go along with them. The scientific program will begin on Sunday, July 22 at 9:30 AM and conclude on Thursday, July 26 at 5:30 PM. Scientific abstracts that scored high during the review process were identified as Reviewers Choice selections. More details on these noteworthy presentations can be found on a special meeting webpage (http://www.aapm.org/meetings/07AM/SpecialRecognition.asp).. ...
Health, ...The 64th Annual Meeting of the American Physical Societys (APS) Divis...The meeting will take place November 20-22 2011 at the Baltimore Con...Preliminary Meeting Highlights ...SUNDAY NOVEMBER 20 ...,APS,Division,of,Fluid,Dynamics,meeting:,Highlights,and,media,registration,medicine,medical news today,latest medical news,medical newsletters,current medical news,latest medicine news
Bulletin Board: A Post From the Community | The North Suburban YMCA will open its doors to the public on Wednesday, October 2 for its 45th Annual Meeting and reception. The Y will introduce new officers to its Board of Directors, honor special contributions from staff and donors, and recap the dramatic growth that has taken place since the completion of renovations in 2012. The reception begins at 6:00pm in the Y¿s lobby, 2705 Techny Road in Northbrook, with the business meeting beginning at 6:45 pm. The new Board leaders include President Jeff Knipp; Vice Presidents Ron Bernardi, Sal Manso, and Jill Narens; Treasurer Michael Redstone; and Secretary ...
Cardiovascular disease is the leading cause of death in the United States and imposes an ever increasing burden on health care systems. Rapidly changing technology and the criteria for its use continue to be at the forefront in the diagnosis and treatment of patients presenting with possible cardiovascular disease. Due to advancing technologies in cardiovascular imaging, it is essential that we close the knowledge, competence, and performance gaps by bringing together experts in the field to provide peer-to-peer education and interactive discussion through case-based, didactic, and interactive sessions. Cardiologists, radiologists, technologists, and other clinicians with an interest in cardiovascular disease will benefit from the varied formats at the SCCT Annual Scientific Meeting (ASM). SCCT has designed ASM to address and narrow the practice gaps of its members.. Upcoming SCCT Annual Scientific Meetings. SCCT2018 Annual Scientific Meeting ...
At the Society of Toxicology 58th Annual Meeting and ToxExpo from March 10th to 14th at the Baltimore Convention Center, Dr Michael Morton of ApconiX will be giving a talk as part of the workshop Can we panelize seizure?. On Wednesday March 13th 9:30am - 10:00am in the Convention Center Ballroom III. An Innovations in Applied Toxicology designated session.. Using Ion Channels to Panelize Seizure: Where Are We Up To?. Authors: M. Morton. ApconiX, Alderley Edge, United Kingdom. Sponsor: J. Pierson. Abstract:. There is clear evidence for the involvement of ion channels in seizure. Genetic studies have pointed to a role for voltage-gated sodium and potassium channels and the ligand-gated ion channels, GABA-A and nicotinic acetylcholine receptors. Pharmacologically, a number of ion channel modulators are known to be seizurogenic such as Chlorpromazine. Should we therefore be looking to screen compounds in early discovery against a panel of ion channels, and what would this panel look like? Ion ...
Author Disclosures: T. Ueland: None. A. Åkerblom: Research Grant; Significant; AstraZeneca (institutional grant), Roche (institutional grant). T. Ghukasyan: Research Grant; Significant; AstraZeneca (institutional grant), Roche (institutional grant). A.E. Michelsen: None. P. Aukrust: None. R.C. Becker: Consultant/Advisory Board; Modest; Janssen (scientific advisory board member), AstraZeneca (scientific advisory board member), Portola (safety reviewing committee member), Merck. M. Bertilsson: Research Grant; Significant; AstraZeneca (institutional grant), Roche (institutional grant). A. Himmelmann: Employment; Significant; AstraZeneca. S.K. James: Research Grant; Significant; AstraZeneca (institutional grant), Abbot vascular (institutional grant), Roche (institutional grant). Honoraria; Modest; AstraZeneca, The Medicines Company, Bayer. Consultant/Advisory Board; Modest; AstraZeneca. A. Siegbahn: Research Grant; Significant; Bristol-Myers Squibb (institutional grant), AstraZeneca (institutional ...
Here are some presentations from the NASPCC 14th Annual Meeting.. Use the links below to download the PowerPoint presentation slides for each presentation. Files in PDF are so indicated. A plugin or additional software is required to view this content.. ...